文献速递肿瘤 PET/CT放射性药物与辐射防护

重新利用分子影像与传感技术用于癌症影像引导手术

Repurposing Molecular Imaging and Sensing for Cancer Image-Guided Surgery.
PubMed 文献 · J Nucl Med · 2020-04-17

本综述总结了用于手术引导的分子影像与传感方法的现状,涵盖核素、光学和多模态方法的特点、优势、局限和临床应用,并提供了一个识别对比机制、合适模态和设备的框架,以应对当前方法日益增加的复杂性和多样性。

要点

  • 分子影像已将影像信息扩展至病理生理和分子过程,18F-FDG PET是其代表。
  • 影像引导手术为外科肿瘤医生和介入放射科医生提供宏观与微观的癌症视图。
  • 低成本便携影像系统使部分技术作为全球手术实践标准的论点成立。

核心结论

  • 分子影像与传感方法可用于癌症手术引导,核素、光学和多模态方法各有其优势、局限和临床应用。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 分子影像扩展了影像信息内容,包括病理生理和分子过程。
  • 癌症影像利用分子影像剂和技术进步提高了肿瘤检测准确性、探究了肿瘤异质性、监测了治疗反应、聚焦了手术切除并实现了影像引导活检。
  • 外科医生正积极利用医学影像提供的机会进行术前规划、术中引导和术后监测。
  • 影像引导手术在手术室中为外科肿瘤医生和介入放射科医生提供癌症的宏观和微观视图。
  • 低成本、便携且用户友好的影像系统使部分技术作为全球手术实践标准的论点成立。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gone are the days when medical imaging was used primarily to visualize anatomic structures. The emergence of molecular imaging (MI), championed by radiolabeled 18F-FDG PET, has expanded the information content derived from imaging to include pathophysiologic and molecular processes. Cancer imaging, in particular, has leveraged advances in MI agents and technology to improve the accuracy of tumor detection, interrogate tumor heterogeneity, monitor treatment response, focus surgical resection, and enable image-guided biopsy. Surgeons are actively latching on to the incredible opportunities provided by medical imaging for preoperative planning, intraoperative guidance, and postoperative monitoring. From label-free techniques to enabling cancer-selective imaging agents, image-guided surgery provides surgical oncologists and interventional radiologists both macroscopic and microscopic views of cancer in the operating room. This review highlights the current state of MI and sensing approaches available for surgical guidance. Salient features of nuclear, optical, and multimodal approaches will be discussed, including their strengths, limitations, and clinical applications. To address the increasing complexity and diversity of methods available today, this review provides a framework to identify a contrast mechanism, suitable modality, and device. Emerging low-cost, portable, and user-friendly imaging systems make the case for adopting some of these technologies as the global standard of care in surgical practice.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mondal SB, O'Brien CM, Bishop K, et al. Repurposing Molecular Imaging and Sensing for Cancer Image-Guided Surgery. J Nucl Med. 2020. PMID: 32303598. doi:10.2967/jnumed.118.220426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。